期刊文献+

大肠杆菌耐喹诺酮类药物机制研究进展

下载PDF
导出
摘要 综述了大肠杆菌耐喹诺酮类抗菌药物的基因机制,可为大肠杆菌耐喹诺酮类抗菌药物药研究提供参考。
出处 《长江大学学报(自科版)(中旬)》 CAS 2012年第7期42-43,52,共3页 Journal of Yangtze University(Nature Science Edition)
  • 相关文献

参考文献16

  • 1Rowe-Magnus D A, Mazel D. The role of integrons in antibiotic resistance gene capture[J]. Int J Med Microbiol, 2002,292:115-125.
  • 2Easson N, Greub G. Resistance of different Chlamydia-like organisms to quinolones and mutations in the quinoline resistance-determi2 aing region of the DNA gyrase A and topoisomerase-encoding genes [J]. Int J Antimicrob Agents, 2006, 27: 541-544.
  • 3Niwa H, Hobo S, Anzai T. A nucleotide mutation associated with fluoroquinolone resistance observed in gyrA of in vitro obtained Rhodococcus equimutants [J]. Vet Microbiol, 2006, 115: 264-268.
  • 4伞治豪.动物源性大肠杆菌主要耐药基因的克隆及其同源性研究[D].长春:吉林农业大学,2008.
  • 5Thomas Gruger, John L Nitiss, Anthony Maxwell, et al. A Mutation in Escherichia coli DNA Gyrase Conferring Quinolone Resist- ance Results in Sensitivity to Drugs Targetillg Eukaryotic Topoisomerase II. Antimicrobial Agents and Chemotherapy [J]. Journal of Antimierohial Chemotherapy, 2004, 48: 4495-4504.
  • 6Maria del Mar Tavio, Jordi Vila, Joaquim Ruiz. Mechenisms involved in the development of resistance to fluoroquinolones in Esche- richia coli isolates [J] Journal of Antimicrobial Chemotherapy, 1999, 44, 735-742.
  • 7Saenz Y, Zarazaga M, Briflas L, et al. Mutations in gyrA and parC genes in nalidixic acid-resistant Escherichia coli strains from food products, humans and animals [J]. Journal of Antimicrobial Chemotherapy, 2003, 51: 1001-1005.
  • 8杨汉春,陈声,Jianghong Meng,吴清明,查振林,郭鑫.鸡源大肠杆菌对氟喹诺酮类药物的多重耐药性[J].畜牧兽医学报,2003,34(4):398-404. 被引量:33
  • 9廖晓萍,陈杖榴,邓旭明,欧阳红生,曾振灵,叶启薇.耐氟喹诺酮类药物大肠杆菌基因突变耐药机制的研究[J].中国兽医学报,2004,24(1):46-48. 被引量:6
  • 10雷连成,韩文瑜,冯现伟,陈伟.一株多重耐药大肠杆菌耐喹诺酮gyrA基因突变的研究[J].中国预防兽医学报,2002,24(1):7-9. 被引量:1

二级参考文献66

共引文献58

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部